AGP Executive Report
Last update: 10 hours agoOnline Alcohol Crackdown: Iceland’s Directorate of Health says it’s “losing the battle” over online alcohol sales, with weak age checks (ID at purchase just 36% of the time and on delivery only 7%) and more parent complaints as retailers expand since 2020. Tobacco Policy Push: Iceland’s draft bill proposes plain packaging for all tobacco and tighter nicotine rules, including limits on nicotine content and restrictions on flavoured products and distance/home delivery sales. Fibromyalgia Genetics: A major study links fibromyalgia to 26 genetic risk regions, strengthening the case for a biological, nervous-system basis rather than “psychological” pain—using data from millions across multiple countries including Iceland. Dementia Link in Blood: Researchers report higher midlife levels of a blood protein (GDF15) are tied to about double the later dementia rate, with analyses including Icelandic participants. COVID Vaccine Update: The EU authorises Pfizer-BioNTech’s 2026-2027 XFG-adapted COVID-19 vaccine for people 6 months and older, with approval also covering Iceland. Local Health Industry Watch: Alvotech says the FDA has closed its May 2026 inspection of its Reykjavik manufacturing site, classified as VAI, as it advances biosimilar applications. Public Health & Policy: The U.S. House unanimously backed a Down syndrome research program under NIH, aiming to expand trials and study co-occurring conditions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
